Reoperation for malignant astrocytoma
- 1 March 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 39 (3) , 430
- https://doi.org/10.1212/wnl.39.3.430
Abstract
We evaluated 15 consecutive patients with malignant astrocytomas who were reoperated for functional status and survival. Their Karnovsky Performance Status (KPS) was not changed by surgery. None suffered perioperative death, wound infection, or complications. Patients with glioblastoma maintained KPS unchanged for a mean of 13 weeks (median, 10 weeks); with anaplastic astrocytoma, mean, 37.2 weeks (median, 24 weeks). Life spans were approximately twice that of non-reoperated historical controls. Reoperation for patients with recurrent malignant astrocytoma should be seriously considered when a gross total re-resection can be the goal in a patient whose tumor is in an accessible brain region.This publication has 4 references indexed in Scilit:
- Morbidity and mortality of craniotomy for excision of supratentorial gliomasNeurology, 1988
- Reoperation in the Treatment of Recurrent Intracranial Malignant GliomasNeurosurgery, 1987
- Effect of the Extent of Surgical Resection on Survival and Quality of Life in Patients with Supratentorial Glioblastomas and Anaplastic AstrocytomasNeurosurgery, 1987
- Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomasCancer, 1983